Sunzen Biotech Bhd
KLSE:SUNZEN
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| MY |
S
|
Sunzen Biotech Bhd
KLSE:SUNZEN
|
193.1m MYR |
Loading...
|
|
| FR |
|
L'Oreal SA
PAR:OR
|
211.8B EUR |
Loading...
|
|
| UK |
|
Unilever PLC
LSE:ULVR
|
119B GBP |
Loading...
|
|
| IN |
|
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
5.5T INR |
Loading...
|
|
| UK |
|
HALEON PLC
LSE:HLN
|
35.9B GBP |
Loading...
|
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
39.5B USD |
Loading...
|
|
| DE |
|
Beiersdorf AG
XETRA:BEI
|
23.6B EUR |
Loading...
|
|
| JP |
|
Kao Corp
TSE:4452
|
3T JPY |
Loading...
|
|
| IN |
|
Godrej Consumer Products Ltd
NSE:GODREJCP
|
1.3T INR |
Loading...
|
|
| IN |
|
Dabur India Ltd
NSE:DABUR
|
924.4B INR |
Loading...
|
|
| CA |
|
Relevium Technologies Inc
XTSX:RLV
|
12.2B CAD |
Loading...
|
Market Distribution
| Min | -634.5% |
| 30th Percentile | 14.4% |
| Median | 23.9% |
| 70th Percentile | 35.3% |
| Max | 247.9% |
Other Profitability Ratios
Sunzen Biotech Bhd
Glance View
Sunzen Biotech Bhd.is an investment holding company, which engages in biotechnology research and development, and the manufacture and marketing of animal feed supplement products. The company is headquartered in Shah Alam, Selangor. The company went IPO on 2008-10-08. Its segments include Manufacturing and trading of animal health products (AH), Trading of crude palm oil products (CPO), Traditional Chinese medicines, herbal foods and beverages, bird's nest (TCM) and Loan financing. The company specializes in animal health and nutrition, manufactures and markets a range of related products for both livestock and companion animals. The company is also involved in the palm oil trading business, which entails the trading of crude palm oil and its derivative products. Its product categories include feed additive, oral pump, functional red palm oil, injectables, water soluble, detergent and disinfection and premix. Its animal health products are offered to domestic and overseas markets in countries, such as China, Korea and the Middle East.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Sunzen Biotech Bhd is 31.4%, which is above its 3-year median of 19.8%.
Over the last 2 years, Sunzen Biotech Bhd’s Gross Margin has increased from 24.6% to 31.4%. During this period, it reached a low of 5.1% on Sep 30, 2024 and a high of 31.4% on Jun 30, 2025.
